BTIG Remains Positive on NeoGenomics (NEO) Following Q4 Results, Guidance; Affirms at 'Buy'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to BTIG Remains Positive on NeoGenomics (NEO) Following Q4 Results, Guidance; Affirms at 'Buy'

NeoGenomics (NEO) Tops Q4 EPS by 3c

March 1, 2016 7:06 AM EST

NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.05, $0.03 better than the analyst estimate of $0.02. Revenue for the quarter came in at $27.3 million versus the consensus estimate of $26.46 million.

GUIDANCE:

NeoGenomics sees FY2016 EPS of $0.07-$0.12, versus the consensus of $0.07. NeoGenomics sees... More